Literature DB >> 24464759

Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats.

Ammar Imad Hazim1, Surash Ramanathan, Suhanya Parthasarathy, Mustapha Muzaimi, Sharif Mahsufi Mansor.   

Abstract

The effects of mitragynine on anxiety-related behaviours in the open-field and elevated plus-maze tests were evaluated. Male Sprague-Dawley rats were orally treated with mitragynine (10, 20 and 40 mg/kg) or diazepam (10 mg/kg) 60 min before behavioural testing. Mitragynine doses used in this study were selected on the basis of approximately human equivalent doses with reference to our previous literature reports. Acute administration of mitragynine (10, 20 and 40 mg/kg) or diazepam (10 mg/kg) increased central zone and open arms exploration in the open-field and elevated plus-maze tests respectively. These anxiolytic-like effects of mitragynine were effectively antagonized by intraperitoneal administration of naloxone (2 mg/kg), flumazenil (10 mg/kg), sulpiride (0.5 mg/kg) or SCH 23390 (0.02 mg/kg) 15 min before mitragynine treatments. These findings reveal that the acute administration of mitragynine produces anxiolytic-like effects and this could be possibly attributed to the interactions among opioidergic, GABAergic and dopaminergic systems in brain regions involved in anxiety.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24464759     DOI: 10.1007/s12576-014-0304-0

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  45 in total

1.  The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.

Authors:  Ercan Ozdemir; Sinan Gursoy; Ihsan Bagcivan
Journal:  J Physiol Sci       Date:  2012-04-29       Impact factor: 2.781

Review 2.  Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.

Authors:  Susanne Nikolaus; Christina Antke; Markus Beu; Hans-Wilhelm Müller
Journal:  Rev Neurosci       Date:  2010       Impact factor: 4.353

3.  Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor.

Authors:  K Watanabe; S Yano; S Horie; L T Yamamoto
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

4.  The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice.

Authors:  M C Hellión-Ibarrola; D A Ibarrola; Y Montalbetti; M L Kennedy; O Heinichen; M Campuzano; J Tortoriello; S Fernández; C Wasowski; M Marder; T C M De Lima; S Mora
Journal:  J Ethnopharmacol       Date:  2005-12-28       Impact factor: 4.360

5.  Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.

Authors:  R P Dilts; P W Kalivas
Journal:  Brain Res       Date:  1989-05-29       Impact factor: 3.252

6.  Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats.

Authors:  Azadeh Sabetghadam; Surash Ramanathan; Sreenivasan Sasidharan; Sharif Mahsufi Mansor
Journal:  J Ethnopharmacol       Date:  2013-02-17       Impact factor: 4.360

7.  Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors.

Authors:  K Matsumoto; M Mizowaki; T Suchitra; H Takayama; S Sakai; N Aimi; H Watanabe
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

Review 8.  Oxytocin: a therapeutic target for mental disorders.

Authors:  Mitsuhiro Matsuzaki; Hiroaki Matsushita; Kazuhito Tomizawa; Hideki Matsui
Journal:  J Physiol Sci       Date:  2012-09-25       Impact factor: 2.781

Review 9.  [Interactions between benzodiazepines and opioids].

Authors:  Bruno Megarbane; Papa Gueye; Frédéric Baud
Journal:  Ann Med Interne (Paris)       Date:  2003-11

10.  Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth.) on the rat gastrointestinal tract.

Authors:  Somsmorn Chittrakarn; Kitja Sawangjaroen; Supaporn Prasettho; Benjamas Janchawee; Niwat Keawpradub
Journal:  J Ethnopharmacol       Date:  2007-11-28       Impact factor: 4.360

View more
  10 in total

1.  Lateral habenular norepinephrine contributes to states of arousal and anxiety in male rats.

Authors:  Erin M Purvis; Adam K Klein; Aaron Ettenberg
Journal:  Behav Brain Res       Date:  2018-03-09       Impact factor: 3.332

2.  Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats.

Authors:  Illa S Johari; Norsyifa Harun; Zarif M Sofian; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2021-08-01       Impact factor: 4.530

3.  Pharmacokinetics and Safety of Mitragynine in Beagle Dogs.

Authors:  Elizabeth A Maxwell; Tamara I King; Shyam H Kamble; Kanumuri Siva Rama Raju; Erin C Berthold; Francisco León; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy; Abhisheak Sharma
Journal:  Planta Med       Date:  2020-07-21       Impact factor: 3.352

4.  Ameliorative Effects of α-Tocopherol and/or Coenzyme Q10 on Phenytoin-Induced Cognitive Impairment in Rats: Role of VEGF and BDNF-TrkB-CREB Pathway.

Authors:  Marwa M Nagib; Mariane G Tadros; Rania M Rahmo; Nagwa Ali Sabri; Amani E Khalifa; Somaia I Masoud
Journal:  Neurotox Res       Date:  2018-10-29       Impact factor: 3.911

Review 5.  The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Authors:  Jack E Henningfield; Reginald V Fant; Daniel W Wang
Journal:  Psychopharmacology (Berl)       Date:  2017-12-23       Impact factor: 4.530

6.  GABA and 5-HT Systems Are Involved in the Anxiolytic Effect of Gan-Mai-Da-Zao Decoction.

Authors:  Hong-Shu Chen; Li-Jia Gu; Yuan-Xiao Yang; Jian-You Guo
Journal:  Front Neurosci       Date:  2019-01-22       Impact factor: 4.677

7.  Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Kelly E Dunn; Oliver Grundmann; Christopher R McCurdy; Destiny Schriefer; David H Epstein
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

8.  Kratom pharmacology: Clues from planarians exposed to mitragynine.

Authors:  Sarah Uddin; Sonita Wiah; Tony Kim; Mia N Watson; Tyra Jennings; Scott M Rawls
Journal:  Physiol Behav       Date:  2021-06-17

Review 9.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

Review 10.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.